As of 2025-09-17, the Relative Valuation of Terns Pharmaceuticals Inc (TERN) is (20.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.30 USD, the upside of Terns Pharmaceuticals Inc based on Relative Valuation is -382.4%.
The range of the Relative Valuation is (19.99) - (20.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 19.9x | 18.8x |
| Forward P/E multiples | 19.1x - 21.7x | 20.5x |
| Fair Price | (19.99) - (20.90) | (20.61) |
| Upside | -373.9% - -386.3% | -382.4% |
| Date | P/E |
| 2025-09-12 | -6.89 |
| 2025-09-11 | -7.09 |
| 2025-09-10 | -7.12 |
| 2025-09-09 | -7.20 |
| 2025-09-08 | -6.94 |
| 2025-09-05 | -6.88 |
| 2025-09-04 | -6.73 |
| 2025-09-03 | -7.09 |
| 2025-09-02 | -7.21 |
| 2025-08-29 | -6.63 |
| 2025-08-28 | -6.74 |
| 2025-08-27 | -6.57 |
| 2025-08-26 | -6.91 |
| 2025-08-25 | -6.38 |
| 2025-08-22 | -6.61 |
| 2025-08-21 | -6.44 |
| 2025-08-20 | -6.01 |
| 2025-08-19 | -6.24 |
| 2025-08-18 | -6.44 |
| 2025-08-15 | -6.72 |
| 2025-08-14 | -6.45 |
| 2025-08-13 | -6.19 |
| 2025-08-12 | -6.22 |
| 2025-08-11 | -6.01 |
| 2025-08-08 | -5.80 |
| 2025-08-07 | -5.38 |
| 2025-08-06 | -5.41 |
| 2025-08-05 | -5.80 |
| 2025-08-04 | -5.48 |
| 2025-08-01 | -5.21 |
| 2025-07-31 | -5.56 |
| 2025-07-30 | -5.63 |
| 2025-07-29 | -5.48 |
| 2025-07-28 | -5.67 |
| 2025-07-25 | -5.77 |
| 2025-07-24 | -5.78 |
| 2025-07-23 | -5.81 |
| 2025-07-22 | -5.72 |
| 2025-07-21 | -5.38 |
| 2025-07-18 | -5.38 |
| 2025-07-17 | -5.34 |
| 2025-07-16 | -5.02 |
| 2025-07-15 | -4.81 |
| 2025-07-14 | -4.87 |
| 2025-07-11 | -4.67 |
| 2025-07-10 | -4.64 |
| 2025-07-09 | -4.66 |
| 2025-07-08 | -4.32 |
| 2025-07-07 | -3.81 |
| 2025-07-03 | -4.12 |